Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Time Trends in Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention: Meta-Analysis on Sex Differences Publisher



Shojaei S1, 2 ; Mousavi A1, 2 ; Soleimani H1, 2 ; Takaloo F1, 2 ; Roudsari PP1, 2 ; Salabat D1, 2 ; Shahmohamady A1, 2 ; Mehrani M1, 2 ; Seilani P1, 2 ; Ashraf H1, 2 ; Nelson J3 ; Thachil R4 ; Iskander F5 ; Khan SU6 Show All Authors
Authors
  1. Shojaei S1, 2
  2. Mousavi A1, 2
  3. Soleimani H1, 2
  4. Takaloo F1, 2
  5. Roudsari PP1, 2
  6. Salabat D1, 2
  7. Shahmohamady A1, 2
  8. Mehrani M1, 2
  9. Seilani P1, 2
  10. Ashraf H1, 2
  11. Nelson J3
  12. Thachil R4
  13. Iskander F5
  14. Khan SU6
  15. Khurram N7
  16. Hosseini K1, 2
Show Affiliations
Authors Affiliations
  1. 1. Cardiac Primary Prevention Research Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Tehran Heart Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. California Cardiovascular Institute, CA, United States
  4. 4. Elmhurst Hospital Center/Mount Sinai School of Medicine, New York, United States
  5. 5. MedStar Union Memorial Hospital, MD, United States
  6. 6. Internal Medicine Department, West Virginia University Hospitals, WV, United States
  7. 7. DeBakey Heart and Vascular Center, Houston Methodist Hospital, Houston, United States

Source: JACC: Advances Published:2025


Abstract

Background: Percutaneous coronary intervention (PCI) is considered the procedure of choice for patients with acute coronary syndrome (ACS), as it significantly improves cardiovascular outcomes. However, considerable uncertainty persists regarding the potential sex differences in PCI outcomes, due to conflicting results in previous studies. Objectives: This meta-analysis aims to evaluate potential sex-related differences in cardiovascular adverse outcomes after PCI among ACS patients. Methods: The primary outcome was major adverse cardiovascular events (MACE) and its components. Outcomes were examined in various time frames including: short-term (within 1 month after PCI), mid-term (within 1 year), and long-term (within >1 year). A random effects model was used to estimate risk ratios (RR) and 95% CIs. Results: Among 32 trials, at short-term, PCI was associated with a higher risk of MACE (risk ratio [RR]: 1.43; 95% CI: 1.10-1.86), all-cause mortality (RR: 2.51; 95% CI: 1.70-3.71), and myocardial infarction (RR: 1.33; 95% CI: 1.00-1.77) in women compared with men. Over the long-term, women had a higher risk of MACE (RR: 1.11; 95% CI: 1.01-1.22), all-cause mortality (RR: 1.29; 95% CI: 1.17-1.42), and cardiovascular mortality (RR: 1.30; 95% CI: 1.11-1.52), when compared with men. However, the analysis for stroke and repeat revascularization showed no significant difference between the 2 groups in the long- and short-term. Conclusions: In the meta-analysis of PCI-related trials in ACS, women have a higher risk of adverse cardiovascular outcomes compared with men. © 2025 The Authors